The University of Chicago Header Logo

Connection

Harvey M. Golomb to Carcinoma, Small Cell

Back to Details
This is a "connection" page, showing publications Harvey M. Golomb has written about Carcinoma, Small Cell.
Harvey M. Golomb
Connection Strength
0.493
Carcinoma, Small Cell
  1. Phase II study of carboplatin in previously untreated patients with metastatic small cell lung carcinoma. Cancer Treat Rep. 1987 Mar; 71(3):311-2.
    View in: PubMed
    Score: 0.070
  2. A 10-year experience with combined modality therapy for stage III small cell lung carcinoma. Cancer. 1986 Nov 15; 58(10):2177-84.
    View in: PubMed
    Score: 0.069
  3. Current concepts in small cell carcinoma of the lung. CA Cancer J Clin. 1984 Sep-Oct; 34(5):269-81.
    View in: PubMed
    Score: 0.059
  4. Lack of efficacy of vinblastine and cisplatin in patients with progressive small cell carcinoma of the lung. Cancer Treat Rep. 1983 Sep; 67(9):831-2.
    View in: PubMed
    Score: 0.055
  5. Gallium 67 scans in small cell carcinoma. JAMA. 1979 Mar 16; 241(11):1106.
    View in: PubMed
    Score: 0.040
  6. Hexamethylmelamine, bleomycin, and CCNU chemotherapy for patients with squamous cell carcinoma, large cell carcinoma, and adenocarcinoma of the lung unresponsive to cyclophosphamide, adriamycin, methotrexate, and procarbazine. Cancer Treat Rep. 1978 Apr; 62(4):567-9.
    View in: PubMed
    Score: 0.038
  7. Adriamycin-radiotherapy interaction. Ann Intern Med. 1977 Jan; 86(1):117.
    View in: PubMed
    Score: 0.035
  8. The role of adjuvant therapy after resection of T1 N1 M0 and T2 N1 M0 non-small cell lung cancer. J Thorac Cardiovasc Surg. 1986 Mar; 91(3):344-9.
    View in: PubMed
    Score: 0.016
  9. Large cell carcinoma of the lung. Ultrastructural differentiation and clinicopathologic correlations. Cancer. 1985 Oct 01; 56(7):1618-23.
    View in: PubMed
    Score: 0.016
  10. Combined modality therapy for Stage IIIMO non-small cell lung cancer. A five-year experience. Cancer. 1984 Jul 01; 54(1):5-12.
    View in: PubMed
    Score: 0.015
  11. Non-small cell carcinoma of the lung. Semin Oncol. 1983 Mar; 10(1):1-122.
    View in: PubMed
    Score: 0.013
  12. Chemotherapy of metastatic non-small cell bronchogenic carcinoma. Semin Oncol. 1983 Mar; 10(1):111-22.
    View in: PubMed
    Score: 0.013
  13. VP16-213 in combined modality treatment of small cell carcinoma of the lung. Eur J Cancer Clin Oncol. 1982 Apr; 18(4):343-6.
    View in: PubMed
    Score: 0.012
  14. Small-cell carcinoma of the lung: a five-year experience with combined modality therapy. Cancer. 1980 Dec 15; 46(12):2550-6.
    View in: PubMed
    Score: 0.011
  15. Lung cancer: A combined modality approach to staging and therapy. CA Cancer J Clin. 1979 Sep-Oct; 29(5):258-75.
    View in: PubMed
    Score: 0.010
  16. Letter: Prolonged survival of patients with extensive oat cell carcinoma treated with radiotherapy and cyclophosphamide (NSC-26271), vincristine (NSC-67574), and methotrexate (NSC-7040). Cancer Treat Rep. 1976 Mar; 60(3):221-3.
    View in: PubMed
    Score: 0.008
  17. Treatment of modified Stage II (T1 N1 M0, T2 N1 M0) non-small cell bronchogenic carcinoma. A combined modality approach. J Thorac Cardiovasc Surg. 1983 Aug; 86(2):180-5.
    View in: PubMed
    Score: 0.003
  18. Metastatic non-small cell bronchogenic carcinoma: a randomized trial of sequential vs combination chemotherapy. Eur J Cancer Clin Oncol. 1983 Jan; 19(1):33-8.
    View in: PubMed
    Score: 0.003
  19. Bronchogenic carcinoma located in the aortic window. The importance of the primary lesion as a determinant of survival. J Thorac Cardiovasc Surg. 1982 Apr; 83(4):551-62.
    View in: PubMed
    Score: 0.003
  20. Sequential staging in bronchogenic carcinoma. Chest. 1979 Dec; 76(6):653-7.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.